Here are three facts:
1. Mr. Blackford currently holds only 2,599 shares.
2. Out of 15 analysts covering NuVasive, 14 rate it “buy,” one “sell,” while six rate it “hold.”
3. Since March 2015, the stock had zero insider buys, and seven insider sales for $3.55 million in net activity.
More articles on devices:
SI-BONE, Aurora Spine, Xtant Medical & more — 25 key notes
NuVasive President & COO Patrick Miles sells 5k shares: 4 points
New study and licensing agreement for InVivo Therapeutics — 3 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
